Evidence map›Paper›PMID 28627172›Full record

ArticleJournal of the American Chemical Society2017

Regiodivergent Glycosylations of 6-Deoxy-erythronolide B and Oleandomycin-Derived Macrolactones Enabled by Chiral Acid Catalysis.

Jia-Hui Tay, Alonso J Argüelles, Matthew D DeMars, Paul M Zimmerman, David H Sherman, Pavel Nagorny

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 78 citations in OpenAlex.

  1. Catalytic Enantioselective Elimination of Cyclobutanols.Journal of the American Chemical Society · 2026
    Article
  2. Review
  3. New Marine Actinobacteria Strain,Microorganisms · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jia-Hui TayDepartment of Chemistry, †Life Sciences Institute, §Department of Medicinal Chemistry, ‡Department of Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-6858-6779
Alonso J ArgüellesDepartment of Chemistry, †Life Sciences Institute, §Department of Medicinal Chemistry, ‡Department of Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Matthew D DeMarsDepartment of Chemistry, †Life Sciences Institute, §Department of Medicinal Chemistry, ‡Department of Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.
Paul M ZimmermanDepartment of Chemistry, †Life Sciences Institute, §Department of Medicinal Chemistry, ‡Department of Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.
David H ShermanDepartment of Chemistry, †Life Sciences Institute, §Department of Medicinal Chemistry, ‡Department of Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-8334-3647
Pavel NagornyDepartment of Chemistry, †Life Sciences Institute, §Department of Medicinal Chemistry, ‡Department of Microbiology & Immunology, University of Michigan , Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-7043-984X
University of Michigan · US

Funding

Cellular Biotechnology Training Program (CBTP)T32GM008353 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, ANNA · 1991 to 2021
$9.3M
Discovery and Characterization of Natural Product Systems-Research Supplement to Promote DiversityR35GM118101 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHERMAN, DAVID H · 2016 to 2025
$3.3M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
New methods and strategies for the synthesis of bioactive steroids and terpinoids SUPPLEMENTR01GM111476 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NAGORNY, PAVEL · 2014 to 2018
$1.5M
NIGMS NIH HHS R01 GM111476NIGMS NIH HHS R35 GM118101NIGMS NIH HHS T32 GM008353NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

This work describes the first example of using chiral catalysts to control site-selectivity for the glycosylations of complex polyols such as 6-deoxyerythronolide B and oleandomycin-derived macrolactones. The regiodivergent introduction of sugars at the C3, C5, and C11 positions of macrolactones was achieved by selecting appropriate chiral acids as catalysts or through introduction of stoichiometric boronic acid-based additives. BINOL-based chiral phosphoric acids (CPAs) were used to catalyze highly selective glycosylations at the C5 positions of macrolactones (up to 99:1 rr), whereas the use of SPINOL-based CPAs resulted in selectivity switch and glycosylation of the C3 alcohol (up to 91:9 rr). Additionally, the C11 position of macrolactones was selectively functionalized through traceless protection of the C3/C5 diol with boronic acids prior to glycosylation. Investigation of the reaction mechanism for the CPA-controlled glycosylations revealed the involvement of covalently linked anomeric phosphates rather than oxocarbenium ion pairs as the reactive intermediates.

Indexed as

CatalysisErythromycinGlycosylationLactonesMolecular StructureOleandomycinPhosphoric AcidsStereoisomerismErythromycinerythronolide BLactonesOleandomycinphosphoric acidPhosphoric Acids

Identifiers

PMID28627172
PMCPMC5553906
OpenAlexW2652087990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.